3-(5-METHOXYPYRIDIN-3-YL)PROPANOIC ACID, 95.0%, 5g

2-Iodo-n-methylacetamide, 98%, 250mg

1-(3-Methoxypropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

4-Methyl-4'-nitro-1,1'-biphenyl, 95.0%, 1g

Regorafénib N-oxyde (M2), 10mg

N-[4-Fluoro-3-(prop-2-enamido)phenyl]-1-(2-fluorophenyl)-1H-pyrazole-4-carboxamide, 98.0%, 250mg

1-(4-Bromophenyl)cyclopentanecarbonitrile, 95.0%, 25g

Methyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate, 95.0%, 1g

4-Bromo-2,5-difluorophenyl isothiocyanate, 95.0%, 1g

4-(chlorosulfonyl)-3-fluorobenzoic acid, 97.0%, 250mg

1,3-Dibromo-2-(3-bromopropoxy)benzene, 98%, 10g

1-METHYLPIPERAZINE-2,5-DIONE, 95.0%, 250mg

1-Chloroadamantane, min. 98%, for synthesis, 5 g, glass packaging